Toxicology testing is helping medical businesses to identify health hazards associated with chemicals, drugs, and other substances, allowing for the development of safe products. Consumers and regulatory agencies expect companies to provide evidence of the safety of their products, which can enhance public trust and brand reputation. Proper toxicology testing can help mitigate the legal risks and potential liabilities of using hazardous substances. New technology, such as High-Throughput Screening (HTS), involves rapidly testing large numbers of compounds for their potential toxicity, allowing for more efficient screening of potential hazards.
The global toxicology testing market is projected to increase by $27.5 bn, growing at a CAGR of 15.09 percent between 2022 and 2027. Several factors drive the market’s growth, including a rise in toxicology testing in the food industry and the widespread use of toxicology testing in pharmaceuticals and biotechnology. Toxicology testing markets are fragmented, with global and regional vendors competing. Vendors constantly develop innovation and advanced testing to meet different end-user industries’ needs. Companies focus on organic and inorganic strategies to strengthen their market positions, including technological innovations and mergers and acquisitions.
This edition of Pharma Tech Outlook Europe brings recent trends and developments in toxicology testing and the latest technologies, making it more crucial for businesses to safeguard the safety of their products and maintain public trust in the pharma sector.
It features a thought leadership article from Ulf Andersson, Head of Preclinical Safety and Translational Pharmacology at Debiopharm, who sheds light on how AI models hold great promise in predicting toxicity and drug combinations, although many existing algorithms lack interpretability. It also features an article from Antti Haapalinna, Vice President of External Science and Partnering, R&D at Orion, who emphasizes the urgent need for better-performing models in terms of speed and better prediction with in-silico models, in-vitro and in-vivo tools to characterize the complex dose[1]exposure-response relationship in early drug discovery.
In this edition, we also bring you the story of some top toxicology testing companies delivering innovative technologies in the pharma sector. One of them is PreClinical Safety (PCS) Consultants, a trusted partner in the pharmaceutical industry due to its unwavering commitment to excellence. The consultancy differentiates itself by offering high-quality, hands-on expertise.
This edition features top Toxicology Services Providers in Europe 2023, ensuring safety and keeping up with the latest trends and technologies. We hope you find the right partner to meet business needs.
